Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
Akamai Technologies announced its definitive agreement to acquire LayerX, a provider of browser-based AI usage control and secure enterprise browser technology, for approximately $205 million. This acquisition aims to enhance Akamai's Zero Trust security solutions by extending protection to browser-level AI interactions, addressing a critical secur…
EyePoint, Inc. announced the independent Data Safety Monitoring Committee (DSMC) has completed its third positive review of the Phase 3 trials for DURAVYUTM, a sustained-release intravitreal treatment for wet age-related macular degeneration (wet AMD). The DSMC recommends continuation of the ongoing LUGANO and LUCIA trials without modifications, ba…
Fiserv has launched agentOS, an agentic AI operating system designed to help banks and credit unions deploy, manage, and scale AI agents securely across key workflows. Built into Fiserv's platforms and developed with six financial institutions, agentOS features a native marketplace with first-party and third-party AI agents targeting risk managemen…
Destination XL Group, Inc., a leading retailer specializing in Big + Tall men's apparel, will release its first quarter fiscal 2026 financial results before market open on May 28, 2026. The company will host a conference call and webcast to discuss the results, with details provided for investor participation.
CAMP4 Therapeutics announced new preclinical data showing that their lead candidate, CMP-002, significantly improves seizure threshold and severity in a SYNGAP1 haploinsufficient mouse model. These results extend previous evidence of neurodevelopmental benefits and support the planned initiation of a Phase 1/2 clinical trial in SYNGAP1-related diso…
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company developing treatments for gout and kidney diseases, announced a $5 million public offering of common shares and pre-funded warrants priced at $1.88 per share. The offering is subject to customary regulatory approvals and is intended to support the advancement of their clinical pi…
Autolus Therapeutics reported first quarter 2026 net product revenue of $26.2 million, driven by the successful US and UK launches of AUCATZYL, its CAR T-cell therapy for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The company achieved positive gross margin for its ALL business for the first time and is impleme…
Aveanna Healthcare Holdings Inc. announced robust financial results for Q1 2026, highlighting a 15.9% revenue increase to $647.9 million and a 25.2% rise in Adjusted EBITDA to $84.4 million compared to the prior year period. The company raised its 2026 revenue guidance to $2.56-$2.58 billion and Adjusted EBITDA to $328-$332 million, reflecting stro…
Americold has announced a strategic expansion of its cold chain logistics services with PLUS, a Netherlands-based supermarket cooperative. Americold will operate a centralized frozen product distribution center in Barneveld, streamlining PLUS's frozen supply chain across its 440 stores to enhance efficiency and service. This move highlights Americo…
American Shared Hospital Services reported a 15.9% increase in revenue for Q1 2026 driven by expansion in direct patient care services and increased procedure volumes at its Rhode Island and Puebla radiation therapy centers. Gross margins improved by 36.7%, and adjusted EBITDA rose 18.4%. Operating loss narrowed compared to the prior year period, s…
NRx Pharmaceuticals, a clinical-stage biopharmaceutical company focused on CNS disorders, will release its Q1 2026 financial results on May 18, 2026, followed by a conference call. The company is developing therapeutics targeting suicidal depression and related conditions with drug candidates NRX-100 and NRX-101, which have received Fast Track and …
Tonix Pharmaceuticals announced a poster presentation at ISPOR 2026 featuring a retrospective analysis of U.S. real-world claims data on fibromyalgia patients. This follows the August 2025 FDA approval and November 2025 U.S. commercial launch of TONMYA® (cyclobenzaprine HCl sublingual tablets), the first new fibromyalgia treatment in over 15 years.…
Aya Gold & Silver Inc. announced a record Q1 2026 financial performance with revenues of $117M, a 247% increase year-over-year, net income growth of 600%, and strong operating cash flow of $70M. Operationally, consolidated silver equivalent production rose 40% YoY to 1.5M ounces, despite some weather disruptions at the Zgounder mine. The company ad…
NETSOL Technologies, Inc. announced record quarterly revenue of $19.8 million for Q3 fiscal 2026, reflecting 13% year-over-year growth. Recurring subscription revenues increased 11.7%, and non-GAAP EBITDA rose 48.2% to $3.4 million. The company secured a four-year, $50 million contract extension with a tier-one global auto captive customer, boostin…
Tilray Brands, through its BrewDog division, has introduced a new line of nostalgic-flavored ready-to-drink (RTD) cocktails named Wonderland in the UK, starting with Pear Drop Margarita and Fizzy Toffee Apple Martini. The launch aims to disrupt the RTD market with bold, sweet-shop-inspired flavors tailored for modern consumers, backed by strong in-…
Concorde International Group Ltd., a technology-enabled security solutions provider, announced it has secured multi-year contracts worth over US$10 million to deliver integrated security solutions across industrial zones, business districts, and community precincts in Singapore. The contracts involve deployment of the company's proprietary i-Guardi…
Barrick Mining Corporation announced the election of its board of directors, appointment of auditors, and approval of executive compensation at its 2026 Annual Meeting. The company confirmed strong shareholder support for its governance proposals, reinforcing stable management and oversight as it continues operations across 17 countries.
Bitdeer Technologies Group disclosed its first quarter 2026 unaudited financial results, showing significant revenue growth driven by increased mining capacity and AI cloud business expansion. Despite a net loss of $159.5 million, the company achieved a positive adjusted EBITDA of $14.4 million, signaling operational improvements. Bitdeer also prog…
Tiziana Life Sciences announced initial Phase 2 clinical trial results revealing that intranasal foralumab significantly reduces brain inflammation in patients with Multiple System Atrophy (MSA), as measured by PET imaging. This represents the third neurological condition showing marked inflammation reduction with the therapy, which previously show…
GH Research PLC announced its Q1 2026 financial results along with key clinical updates. The company published positive Phase 2b trial results of its lead depression treatment GH001 in JAMA Psychiatry, demonstrating robust remission rates in treatment-resistant depression (TRD). Enrollment completed in Phase 1 studies for dose selection and deliver…
Chicago Atlantic BDC, a specialty finance company focusing on cannabis and middle-market direct lending, reported record first quarter 2026 financial results. The company achieved net investment income of $10.0 million ($0.44 per share), increased its investment portfolio to $364 million, and declared a quarterly dividend of $0.34 per share. The po…
Climb Bio, Inc., a clinical-stage biotech company, announced it will present new clinical data for its investigational drug budoprutug at the European Hematology Association 2026 Congress. The data includes safety and efficacy results from a Phase 1b/2a trial in patients with primary immune thrombocytopenia, highlighting budoprutug’s potential as a…
Cabaletta Bio presented encouraging clinical and translational data for its autologous CAR T cell therapy rese-cel at the ASGCT 2026 Annual Meeting. The data showed that the lowest dose of preconditioning-free rese-cel produced compelling drug-free responses in half of treated refractory patients with pemphigus vulgaris over six months. Additionall…
Willis Lease Finance Corporation announced the pricing of an upsized public offering of $200 million of 2.50% convertible senior notes due 2031, alongside a concurrent offering of borrowed common stock to facilitate hedging transactions. The net proceeds are intended to temporarily repay amounts outstanding under the Company's revolving credit faci…
Ducommun Incorporated will host an Investor Day on September 17, 2026, to update shareholders on progress under its VISION 2027 strategy and to unveil its new five-year strategic plan, VISION 2032. The company plans to highlight growth, investment, and capital allocation strategies aimed at strengthening the company and enhancing shareholder value.…
